Development of an enzyme-linked immunosorbent assay based on the murine leukemia virus p30 capsid protein

Dai Tze Wu, Sriram Aiyer, Rodrigo A. Villanueva, Monica J. Roth

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Retroviral vectors derived from the murine leukemia virus (MuLV) are widely used as the starting material in the development of vectors for gene therapy and critical in answering questions relating to viral pathogenesis. The p30 capsid (CA) is the major viral core protein and an internal group antigen in MuLV. In this study, an enzyme-linked immunosorbent assay (ELISA) was developed for quantitation of MuLV infectious particles with p30 CA core antigen protein. The ELISA was developed using several goat-polyclonal serum against MuLV p30 generated by the NCI as primary antibody and a rat-monoclonal antibody to CA available from ATCC. The MuLV p30 CA antigen was standardized against recombinant MuLV p30 CA expressed from bacteria. The assay is sensitive, accurate and linear within a defined concentration range of CA. Comparison with different MuLV quantitative methods including reporter gene transfer, reverse transcriptase activity assay, and viral RNA quantitative PCR, showed this ELISA protocol to be highly quantifiable within defined ranges, which can be correlated with infectious viral titer.

Original languageEnglish (US)
Pages (from-to)332-336
Number of pages5
JournalJournal of Virological Methods
Issue number2
StatePublished - 2013

All Science Journal Classification (ASJC) codes

  • Virology


  • P30 CA
  • Virus normalization

Fingerprint Dive into the research topics of 'Development of an enzyme-linked immunosorbent assay based on the murine leukemia virus p30 capsid protein'. Together they form a unique fingerprint.

Cite this